Women’s Public Health and Safety Act

For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.

For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of the Pregnant Students Rights Act, which would require institutions of higher education to disseminate information on the rights of, and accommodations and resources for, pregnant students. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria.

assist client with issues pertaining to nutrition programs for women, infants and children and medicare/medicaid. S948 Healthy Moms and Baby Act; S1605 Maternal Health Pandemic Response Act;H.R.1117 Advancing Safe Medications for Moms and Babies Act of 2023; S.842 Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2023; H.R.629 Medicaid Improvement and State Flexibility Act of 2023; H.R.814 Protect Social Security and Medicare Act; H.R.1618 Commission on Sustaining Medicare and Social Security Act of 2023; H.R.1342, H.R.420 Language Access for Medicare Beneficiaries Act of 2023 S.570 - Medicaid Dental Benefit Act of 2023; S.712 Connected MOM Act; S.471 Womens Public Health and Safety Act;

Client expense: Not reported · Firm income: $11,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.842 Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2023; H.R.629 Medicaid Improvement and State Flexibility Act of 2023; H.R.814 Protect Social Security and Medicare Act; H.R.1618 Commission on Sustaining Medicare and Social Security Act of 2023; H.R.1342, H.R.420 Language Access for Medicare Beneficiaries Act of 2023 S.570 - Medicaid Dental Benefit Act of 2023; S.712 Connected MOM Act; S.471 Womens Public Health and Safety Act; S.1296, HR3069 John Lewis Equality in Medicare and Medicaid Treatment Act of 2023; S.1599 Data to Save Moms Act; H.R.4605, S948 - Healthy Moms and Babies Act; HR.4989 - Healthy Babies Act of 2023

Client expense: Not reported · Firm income: $11,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program.

assist client with issues pertaining to nutrition programs for women, infants and children and medicare/medicaid. S948 Healthy Moms and Baby Act; S1605 Maternal Health Pandemic Response Act;H.R.1117 Advancing Safe Medications for Moms and Babies Act of 2023; S.842 Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2023; H.R.629 Medicaid Improvement and State Flexibility Act of 2023; H.R.814 Protect Social Security and Medicare Act; H.R.1618 Commission on Sustaining Medicare and Social Security Act of 2023; H.R.1342, H.R.420 Language Access for Medicare Beneficiaries Act of 2023 S.570 - Medicaid Dental Benefit Act of 2023; S.712 Connected MOM Act; S.471 Womens Public Health and Safety Act;

Client expense: Not reported · Firm income: $11,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.842 Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2023; H.R.629 Medicaid Improvement and State Flexibility Act of 2023; H.R.814 Protect Social Security and Medicare Act; H.R.1618 Commission on Sustaining Medicare and Social Security Act of 2023; H.R.1342, H.R.420 Language Access for Medicare Beneficiaries Act of 2023 S.570 - Medicaid Dental Benefit Act of 2023; S.712 Connected MOM Act; S.471 Womens Public Health and Safety Act; S.1296, HR3069 John Lewis Equality in Medicare and Medicaid Treatment Act of 2023; S.1599 Data to Save Moms Act; H.R.4605, S498 - Healthy Moms and Babies Act; HR.4989 - Healthy Babies Act of 2023

Client expense: Not reported · Firm income: $11,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the U.S. House issued Jan, 10, 2023. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (H.R. 431) and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program.

assist client with issues pertaining to nutrition programs for women, infants and children and medicare/medicaid. S948 Healthy Moms and Baby Act; S1605 Maternal Health Pandemic Response Act;H.R.1117 Advancing Safe Medications for Moms and Babies Act of 2023; S.842 Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2023; H.R.629 Medicaid Improvement and State Flexibility Act of 2023; H.R.814 Protect Social Security and Medicare Act; H.R.1618 Commission on Sustaining Medicare and Social Security Act of 2023; H.R.1342, H.R.420 Language Access for Medicare Beneficiaries Act of 2023 S.570 - Medicaid Dental Benefit Act of 2023; S.712 Connected MOM Act; S.471 Womens Public Health and Safety Act;

Client expense: Not reported · Firm income: $11,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.842 Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2023; H.R.629 Medicaid Improvement and State Flexibility Act of 2023; H.R.814 Protect Social Security and Medicare Act; H.R.1618 Commission on Sustaining Medicare and Social Security Act of 2023; H.R.1342, H.R.420 Language Access for Medicare Beneficiaries Act of 2023 S.570 - Medicaid Dental Benefit Act of 2023; S.712 Connected MOM Act; S.471 Womens Public Health and Safety Act; S.1296, HR3069 John Lewis Equality in Medicare and Medicaid Treatment Act of 2023; S.1599 Data to Save Moms Act.

Client expense: Not reported · Firm income: $11,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts in support of the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the U.S. House issued Jan, 10, 2023. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (H.R. 431) and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program.

S.842 Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2023; H.R.629 Medicaid Improvement and State Flexibility Act of 2023; H.R.814 Protect Social Security and Medicare Act; H.R.1618 Commission on Sustaining Medicare and Social Security Act of 2023; H.R.1342, H.R.420 Language Access for Medicare Beneficiaries Act of 2023 S.570 - Medicaid Dental Benefit Act of 2023; S.712 Connected MOM Act; S.471 Womens Public Health and Safety Act.

Client expense: Not reported · Firm income: $11,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

assist client with issues pertaining to nutrition programs fore women, infants and children and medicare/medicaid. S.842 Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2023; H.R.629 Medicaid Improvement and State Flexibility Act of 2023; H.R.814 Protect Social Security and Medicare Act; H.R.1618 Commission on Sustaining Medicare and Social Security Act of 2023; H.R.1342, H.R.420 Language Access for Medicare Beneficiaries Act of 2023 S.570 - Medicaid Dental Benefit Act of 2023; S.712 Connected MOM Act; S.471 Womens Public Health and Safety Act.

Client expense: Not reported · Firm income: $11,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Endorsed, strategized, supported advancement of H.R.734, the Protection of Women and Girls in Sports Act Endorsed, strategized, supported advancement of S.816, the Protection of Women and Girls in Sports Act Opposed an allocation of CDC grant, "93.391: Activities to Support State, Tribal, Local and Territorial (STLT) Health Department Response to Public Health or Healthcare Crises" Supported Senate Pro-Life Caucus Membership Opposed S.754 (117th) - Ensuring Lasting Smiles Act Supported oversight question for the record about FDA-Certified Abortion Pill Dispensaries on College Campuses Supported oversight question for the record about FDA protocol on establishing regulation over drug manufacturers for drugs to induce abortions Supported oversight question for the record about U.S. Department of Health and Human Services' policy for the Protection of Human Subjects 45 CFR 46 Endorsed H.R.6060 (117th) Conscience Protection Act Endorsed congressional letter to the Food and Drug Administration calling on the administration to safeguard women and childrens health by rescinding its abortion pill regulations Endorsed S.750 - No Taxpayer Funding for Health Centers Providing Abortion Act Endorsed H.R.383- to nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes Endorsed congressional letter to FDA Commissioner Robert Califf, M.D., explaining the policy and legal faults in the FDA decision to approve chemical abortion drugs and then further eliminate the in-person dispensing in an attempt to make abortion drugs available by mail Endorsed S.13 - Protect Funding for Womens Health Care Act Endorsed S.95 - SAVE Moms and Babies Act Endorsed H.R.427 - SAVE Moms and Babies Act Endorsed congressional letter to Secretary of U.S. Department of Health and Human Services Xavier Becerra on oversight of pediatric "gender affirming care" Endorsed S.76 - Standing With Moms Act Endorsed H.R.517 - Standing With Moms Act Endorsed H.R.1074 - Women's Public Health and Safety Act Endorsed S.471 - Women's Public Health and Safety Act Endorsed bicameral comment letter against the elimination of the moral exemptions to the contraceptive mandate regulation Endorsed S.565 - Pregnancy Center Security Act Endorsed H.R.384 - Protecting Life From Chemical Abortions Act